Last updated on December 2016

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest


Brief description of study

This is an open label study in which eligible IPF subjects who are using supplemental oxygen at rest will receive GBT440 orally daily.

Clinical Study Identifier: NCT02989168

Find a site near you

Start Over

Sharonda Keazor

Birmingham, AL United States
  Connect »

Scott Sweeten

Salt Lake City, UT United States
  Connect »

Cori Fratelli

Denver, CO United States
  Connect »

Jim Del Greco

Nashville, TN United States
  Connect »

Sylvia Johnson

Philadelphia, PA United States
  Connect »

Sandy M. Ditta

New Orleans, LA United States
  Connect »